🇺🇸 FDA
Patent

US 7576175

Alpha-4 beta-1 integrin ligands for imaging and therapy

granted A61KA61K38/00A61K45/06

Quick answer

US patent 7576175 (Alpha-4 beta-1 integrin ligands for imaging and therapy) held by The Regents of the University of California expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K45/06